Pro Dex PDEX
NASDAQ PDEX
$65.66 -1.76 (-2.61%)
At close: Nov 13, 2026 · 4:00 PM EST

Pro Dex (PDEX) Income from Continuing Operations (2009 - 2026)

Updated

Pro Dex (PDEX) recorded Income from Continuing Operations of $3.05 million in fiscal Q1 2027 (quarter ended Sep 30, 2026), down 34.9% from $4.68 million a year earlier but up 6.7% from the prior quarter.

Analysis

Pro Dex (PDEX) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a TTM basis, Pro Dex's Income from Continuing Operations came in at $12.03 million as of Sep 30, 2026, up 7.5% year-over-year; for FY2026 (ended Jun 30, 2026), it was $13.66 million, up 52.2% from FY2025.

  • Annual Income from Continuing Operations has a five-year compound annual growth rate of 17.2% (FY2021 to FY2026).
  • Across earlier fiscal years, Income from Continuing Operations came in at $8.98 million in FY2025 (+322.1%), $2.13 million in FY2024 (-69.9%), $7.07 million in FY2023 (+54.7%) and $4.57 million in FY2022 (-25.9%).
  • Quarterly Income from Continuing Operations has ranged from -$615,000 in fiscal Q1 2024 to $4.68 million in fiscal Q1 2026 over the past five years.
  • On a year-over-year basis, Income from Continuing Operations rose in six of the last eight quarters, with growth averaging 113.1%.
  • Peak year-over-year performance for Income from Continuing Operations in the last five years was growth of 400.0% in fiscal Q3 2025, against a decline of 81.8% in fiscal Q2 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $2.86 million (Q4 2026), $3.94 million (Q3 2026) and $2.19 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 1.74 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 920.00 Mn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 1.21 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 524.40 Mn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 1.48 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -237.00 Mn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 580.00 Mn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 301.40 Mn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 318.00 Mn
10 Pro Dex 210.33 Mn 174.25 Mn 6.86 Mn 3.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.05 Mn
Jun 30, 2026 2.86 Mn
Mar 31, 2026 3.94 Mn
Dec 31, 2025 2.19 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 3.28 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 2.47 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 655,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 -615,000.00
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 2.12 Mn
Mar 31, 2022 574,000.00
Dec 31, 2021 1.08 Mn
API Access

Pro Dex Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PDEX&period=max&api_key=YOUR_API_KEY